High expression of SFN was also positively correlated with poor prognosis in 62 NSCLC patients after ATC (p = 0.002; Figure 5E) and in 492 LUAD patients (p = 0.019; Figure 5F) from TCGA dataset. This evidence concerns the gene SFN and non-small cell lung carcinoma.